Common Shares Outstanding: The number of class A shares currently held by investors.
Dyne Therapeutics, Inc. (DYN) had Common Shares Outstanding of 165.67M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-178.56M |
|
-- |
|
-- |
|
$181.66M |
|
$-181.66M |
|
$3.10M |
|
$-178.56M |
|
$-178.56M |
|
$-178.56M |
|
$-178.56M |
|
$-178.56M |
|
$-178.56M |
|
$-181.66M |
|
$-181.33M |
|
165.45M |
|
165.45M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$937.89M |
|
$24.56M |
|
$56.12M |
|
$994.01M |
|
$78.03M |
|
$199.33M |
|
$213.83M |
|
$291.86M |
|
$702.15M |
|
$702.15M |
|
$702.15M |
|
|
Common Shares Outstanding |
165.67M |
| Cash Flow Statement Financials | |
$-275.21M |
|
$-7.19M |
|
$65.17M |
|
$895.74M |
|
$678.52M |
|
$-217.22M |
|
$28.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.02 |
|
-- |
|
-- |
|
0.22 |
|
0.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-276.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.43% |
|
-25.43% |
|
-17.96% |
|
-19.81% |
|
$4.24 |
|
$-1.67 |
|
$-1.66 |
|